Evidence map›Paper›PMID 42985161›Full record

ArticleTherapeutic advances in medical oncology2026

Clinicopathologic and molecular features of head and neck NUT carcinoma: Analysis of 25 cases, including 5 with adenoid differentiation.

Yunyun Yang, Yue Hao, Chunwei Xu, Yahui Li, Xiaochen Li, Honggang Liu, Yingshi Piao

Abstract read
In one paragraph

Article in Therapeutic advances in medical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yunyun YangDepartment of Pathology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, China.ORCID https://orcid.org/0000-0001-7464-2688
Yue HaoJinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, People's Republic of China.ORCID https://orcid.org/0000-0002-4725-6084
Chunwei XuHangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Yahui LiDepartment of Pathology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, China.
Xiaochen LiDepartment of Pathology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, China.
Honggang LiuDepartment of Pathology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, China.
Yingshi PiaoDepartment of Pathology, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nuclear protein in testis (NUT) carcinoma is a highly aggressive malignancy driven by Objective: To characterize the pathological and molecular features of primary head and neck NUT carcinoma and explore optimal management strategies. Design: This study was a single-center retrospective analysis. Methods: Fluorescence in situ hybridization was used to detect Results: This study included 25 patients with NUT carcinoma. Adenoid differentiation was observed in 5 cases (2 Conclusion: Patients with NUT with adenoid differentiation or different gene fusions exhibit distinct gene expression profiles and immune landscapes. Neuroendocrine differentiation is associated with poor prognosis. Radiotherapy may be associated with favourable outcomes and warrants further investigation.

Indexed as

immune landscapemolecular characterizationNUT carcinomaRNA-seqtreatment

Identifiers

PMID42985161
PMCPMC13731889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.